Vida Health
For employees and health plan members seeking clinical support for weight management, diabetes, and behavioral health.
Vida Health is an established health & fitness app that is available. With a 4.4/5 rating from 14.4K reviews, it shows polarized user reception. Users particularly appreciate personalized clinical coaching and support, though technical friction on android platform remains a common concern.
What is Vida Health?
Vida Health is a clinical care platform for chronic condition management, providing multi-disciplinary coaching and medical support to employer-sponsored members on iOS and Android.
Users hire Vida to manage complex health conditions through a unified clinical team, replacing fragmented care with a single, employer-covered digital interface.
Current Momentum
v4.90 · 1d ago
Maintenance- Maintains enterprise-focused clinical coaching model.
- Last major update May 2026.
Active Nemesis
DynamiCare Health
By DynamiCare Health
Other Rivals
7-Day Rank Pulse 🇺🇸
Health & FitnessNo ranking data
Rating Pulse 🇺🇸
Recent User Mood
What makes this app unique?
Loading...
What Are The Key Features?
Access to coaches, dietitians, therapists, and medical providers for personalized health programs
Syncs data from over 100 health devices and apps to share progress with care teams
Clinical weight management support including the prescription of GLP-1 medications
How much does it cost?
- Employer-sponsored access
- Health plan-covered access
B2B-focused model where costs are covered by enterprise partners rather than individual consumer subscriptions.
Who Built It?
Enrichment in progress
Publisher profile available very soon
What other apps does Vida Health make?
What do users think recently?
Medium confidence · Latest 100 of 12.2K total reviews analyzed
How did the latest release land?
What is the recent mood?
Recent user voice shows a mixed sentiment. Users appreciate personalized clinical coaching and support, but report technical friction on android platform.
What Users Love
What Frustrates Users
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for Vida Health?
Where is it available?
Localized markets (1)
How's The Health & Fitness Market?
Market outlook for this category
Available very soon
The rivals identified
Nemeses(1)
Brightside competes directly for the employer-sponsored mental health market, targeting the same clinical outcomes and member populations as Vida Health.
Contenders(4)
This app competes for the same payer-sponsored care management market, focusing on direct messaging and health plan integration.
VagalPath targets the stress-reduction and nervous system regulation segment of Vida's user base with specialized, polyvagal-based exercises.
Calm Health leverages its massive consumer brand equity to enter the employer-sponsored space with condition-specific digital programs.
Grow Therapy challenges Vida by streamlining the connection between patients and insurance-covered providers through a unified digital interface.
Same space(3)
Focuses on patient-reported outcomes and community support, which complements the clinical data tracking found in Vida.
Addresses the crisis intervention and mental health support space, competing for the attention of users in acute distress.
Serves the addiction and recovery segment of the health market, overlapping with Vida's behavioral health coaching services.
Compare Vida Health against every rival
All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.
The outtake for Vida Health
Strengths to defend, gaps to attack
Core Strengths
- Multi-disciplinary care team structure drives clinical outcomes
- 100+ device integrations create high switching costs for enterprise partners
Critical Frictions
- 1.52-star Android-iOS rating gap indicates poor platform parity
- B2B-only access model limits organic user acquisition
Growth Levers
- Education partnerships could serve as a new B2B distribution channel
- Wearable integration expansion for real-time monitoring
Market Threats
- Talkspace's high-frequency messaging model drains daily active usage
- GLP-1 prescription competitors with lower-friction virtual primary care models
What are the next best moves?
Ship Android UI parity updates because the 1.52-star rating gap signals platform-specific churn → stabilize Android retention.
Android rating is 3.15 compared to 4.67 on iOS.
Trade-off: Push the new wearable integration sprint to Q4 — platform parity is a higher churn risk.
Pivot coaching model to include high-frequency messaging because Talkspace's unlimited messaging drives higher daily habit formation → increase daily active usage.
Talkspace competes directly for mental health users with a high-frequency messaging model.
Trade-off: Deprioritize the static content library expansion — messaging frequency has a higher impact on retention.
A counter-intuitive read
Vida's B2B-only model is not a weakness but a moat, as it forces enterprise-level clinical validation that consumer-first therapy apps cannot replicate without massive overhead.
Feature Gaps vs Competitors
- Unlimited messaging therapy (available in Talkspace but absent here)
- 24/7 virtual primary care (available in Accolade Care but absent here)
Key Takeaways
Vida delivers proven clinical results for chronic conditions, but the rigid B2B access model and Android technical friction leave it vulnerable to high-frequency consumer therapy apps, so the PM must prioritize platform parity and messaging frequency to defend the enterprise user base.
Where Is It Heading?
Mixed Signals
The enterprise health market is shifting toward high-frequency, consumer-grade engagement models, leaving Vida's structured coaching approach exposed to attrition. Vida must reconcile its clinical depth with the high-frequency interaction standards set by competitors to maintain its enterprise-sponsored lead.
The 1.52-star Android rating gap indicates technical friction that erodes user trust, which compounds the churn risk against consumer-first competitors.
Clinical outcomes for weight loss and diabetes remain strong, which secures the B2B contract renewals necessary for long-term platform stability.